Venereal Diseases Prevention and Treatment

The event of persistent disease complications in controlled HIV disease changed the landscape of clinical HIV care. HIV disease provides the possibility of advancing cardiovascular disease, which is thought to be caused by a complex interaction of modifying variables. While the usual components of cardiovascular risk likely play a role, HIV-related irritation and safe sanctions were later shown to be a critical transition between cardiovascular risks.

It is unclear whether established preventive distractions for the general population are relevant to HIV-infected patients, and the ability to decode foolproof information into HIV-specific clinical mediations speaks to a fundamental need. Established techniques to avoid cardiovascular disease in HIV-infected persons require a multidisciplinary approach and speak to the opportunity to exert a large open effect on well-being in at-risk populations.


    Related Conference of Venereal Diseases Prevention and Treatment

    April 04-05, 2024

    38th International Conference on Immunology

    Madrid, Spain
    May 23-24, 2024

    18th International Conference on European Immunology

    Zurich, Switzerland

    Venereal Diseases Prevention and Treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in